LoopIQ for 21 CFR Part 11 Release Evidence

FDA-regulated software teams carry a double records burden: the product's records must satisfy predicate rules, and the records of changing the product — approvals, verification results, release clearances — must satisfy 21 CFR Part 11's standards for electronic records and signatures. Most teams meet the first burden with validated product systems and the second with email sign-offs and spreadsheets that fail every Part 11 property at once. LoopIQ closes that gap: a delivery workspace whose change, verification, and release records are attributable, audit-trailed, meaningfully signed, and retrievable by construction.

Key Takeaways: LoopIQ for Part 11

• LoopIQ's records carry Part 11's core properties: authenticated attribution, system-generated audit trails, role-based authority checks, durable retention.
• Approval sign-offs bind identity, role, timestamp, and meaning to the specific artifact — the e-signature substance the rule demands.
• Verification evidence is captured at execution with executor and environment, not transcribed afterward.
• Release certifications provide the signed clearance record, assembled with its evidence in the Release Compliance Dossier.
• LoopIQ supports your validation of the system for intended use — compliance lives in tool plus validation.

The Delivery Records Part 11 Reaches

When software governs regulated processes, changing it produces quality records: who authorized the change, what testing verified it, who cleared the release. Part 11's conditions apply — attributability to authenticated individuals, computer-generated audit trails, tamper-evidence, retention with human-readable retrieval, and signatures that carry meaning. The common stack (chat approvals, CI logs, editable checklists) fails structurally: chat proves nothing about authority or artifact, logs rotate before retention windows close, and a spreadsheet's integrity is whatever its last editor left. Inspectors and auditors read those gaps as systemic.

How LoopIQ Provides the Properties

Attribution and authority. Every action ties to an authenticated user; role and permission management enforces who may author, review, approve, and administer — the authority checks Subpart B requires — within a tenant-safe permission model.

Meaningful sign-offs. Approval policies execute your authorization matrix and record the approver's identity, role, timestamp, and what the approval attested, bound to the specific change request — a signature that can't be excised and reapplied elsewhere.

System-generated verification records. Test executions log results, executor, and environment at run time; CI/CD integrations capture automated suite evidence — no transcription step for an auditor to doubt.

Signed release clearance. Release certifications gate go-live on configured criteria with attributed sign-off, and the Release Compliance Dossier assembles the release's full record set — the human-readable, retrievable copy an inspection requests.

Validation for Intended Use

Part 11 compliance attaches to a validated implementation, not a product label. LoopIQ supports the exercise: stable, documented behaviors to validate against; role configurations that map to your SOPs; and compliance objectives to track the validation evidence itself alongside the delivery evidence it governs. Your quality team defines intended use and executes the qualification; the system's structural properties keep the procedural burden — the SOPs papering over tool gaps — to a minimum.

Where Teams Start

The typical entry point is the change-approval lane on regulated systems: codify the sign-off matrix as approval policy, route changes through structured requests, and let two release cycles build the record. Then extend to verification capture and certification gates, importing Jira history so prior work remains referenceable. The acceptance test mirrors an inspection: produce a release's complete signed record set — approvals with meaning, verification with executors, clearance with criteria — in minutes.

In Conclusion

Part 11 asks a simple question of every delivery record: can you prove who did what, when, with what authority and intent — years later? LoopIQ makes yes the default answer: attribution, trails, meaningful signatures, and retention built into the workflow that ships your regulated software.

FAQs about LoopIQ for 21 CFR Part 11

Which Part 11 properties does LoopIQ provide structurally?

Authenticated attribution on every action, role-based authority checks, policy-enforced sign-offs binding identity, role, timestamp, and meaning to specific artifacts, system-generated capture of verification evidence, and durable human-readable retrieval per release.

How do LoopIQ approvals work as electronic signatures?

Approval policies authenticate the approver, verify their role against the authorization matrix, and record what the approval attested — bound to the specific change request, so the signature can't be excised and reapplied elsewhere.

Does LoopIQ still need validation for intended use?

Yes — Part 11 compliance attaches to a validated implementation. LoopIQ supplies stable documented behaviors and role configurations to validate against; your quality team defines intended use and executes the qualification.

Where do FDA-regulated teams start with LoopIQ?

The change-approval lane on regulated systems: codify the sign-off matrix as approval policy, run two release cycles, then extend to verification capture and certification gates — with the inspection drill as the acceptance test.